Anebulo Pharmaceuticals ANEB

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
-$0.06 (-5.88%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of Anebulo Pharmaceuticals (ANEB)
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Key Insights

Critical company metrics and information

  • Latest Closing Price

    $1.07

  • Market Cap

    $43.96 Million

  • Price-Earnings Ratio

    -11.89

  • Total Outstanding Shares

    41.09 Million Shares

  • Total Employees

    2

  • Dividend

    No dividend

  • IPO Date

    May 7, 2021

  • SIC Description

    Pharmaceutical Preparations

  • Primary Exchange

    NASDAQ

  • Type

    Common Stock

  • Headquarters

    Jfl capital management, Lakeway, TX, 78734

  • Homepage

    https://www.anebulo.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

October 1, 2024 to December 31, 2024
MetricValue
Net Cash Flow From Operating Activities, Continuing$-1.41 Million
Net Cash Flow, Continuing$1.69 Million
Net Cash Flow From Operating Activities$-1.41 Million
Net Cash Flow$1.69 Million

Income Statement

October 1, 2024 to December 31, 2024
MetricValue
Net Income/Loss Available To Common Stockholders, Basic$-2.46 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0
Diluted Average Shares$27.42 Million
Interest Income/Expense After Provision For Losses$100,000
Net Income/Loss Attributable To Parent$-2.46 Million
Preferred Stock Dividends And Other Adjustments$0

Comprehensive Income

October 1, 2024 to December 31, 2024
MetricValue
Comprehensive Income/Loss Attributable To Parent$-2.46 Million
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Comprehensive Income/Loss$-2.46 Million
Other Comprehensive Income/Loss$0

Balance Sheet

October 1, 2024 to December 31, 2024
MetricValue
Prepaid Expenses$366,266
Accounts Payable$319,515
Liabilities And Equity$15.84 Million
Other Current Assets$15.03 Million
Current Liabilities$878,799
Assets$15.84 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about ANEB from trusted financial sources
    All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

    ⓒ 2025 Financhle. All Rights Reserved.